These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33139282)

  • 1. Lack of Specificity of Phenotypic Screens for Inhibitors of the Mycobacterium tuberculosis FAS-II System.
    Grzegorzewicz AE; Lelièvre J; Esquivias J; Angala B; Liu J; Lee RE; McNeil MR; Jackson M
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33139282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Resistance Associated with the Inhibition of the Dehydration Step of Type II Fatty Acid Synthase in
    Grzegorzewicz AE; Gee C; Das S; Liu J; Belardinelli JM; Jones V; McNeil MR; Lee RE; Jackson M
    ACS Infect Dis; 2020 Feb; 6(2):195-204. PubMed ID: 31775512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the assignment of Rv0241c to fatty acid synthase type II of Mycobacterium tuberculosis.
    Sacco E; Slama N; Bäckbro K; Parish T; Laval F; Daffé M; Eynard N; Quémard A
    J Bacteriol; 2010 Aug; 192(15):4037-44. PubMed ID: 20511508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis.
    Sacco E; Covarrubias AS; O'Hare HM; Carroll P; Eynard N; Jones TA; Parish T; Daffé M; Bäckbro K; Quémard A
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14628-33. PubMed ID: 17804795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis.
    Kremer L; Dover LG; Carrère S; Nampoothiri KM; Lesjean S; Brown AK; Brennan PJ; Minnikin DE; Locht C; Besra GS
    Biochem J; 2002 Jun; 364(Pt 2):423-30. PubMed ID: 12023885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a novel dehydratase of the fatty acid synthase type II critical for ketomycolic acid biosynthesis and virulence of Mycobacterium tuberculosis.
    Lefebvre C; Frigui W; Slama N; Lauzeral-Vizcaino F; Constant P; Lemassu A; Parish T; Eynard N; Daffé M; Brosch R; Quémard A
    Sci Rep; 2020 Feb; 10(1):2112. PubMed ID: 32034201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mycobacterium tuberculosis FAS-II dehydratases and methyltransferases define the specificity of the mycolic acid elongation complexes.
    Cantaloube S; Veyron-Churlet R; Haddache N; Daffé M; Zerbib D
    PLoS One; 2011; 6(12):e29564. PubMed ID: 22216317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II.
    Brown AK; Papaemmanouil A; Bhowruth V; Bhatt A; Dover LG; Besra GS
    Microbiology (Reading); 2007 Oct; 153(Pt 10):3314-3322. PubMed ID: 17906131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.
    Slayden RA; Lee RE; Barry CE
    Mol Microbiol; 2000 Nov; 38(3):514-25. PubMed ID: 11069675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.
    Schaeffer ML; Agnihotri G; Volker C; Kallender H; Brennan PJ; Lonsdale JT
    J Biol Chem; 2001 Dec; 276(50):47029-37. PubMed ID: 11600501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point mutations within the fatty acid synthase type II dehydratase components HadA or HadC contribute to isoxyl resistance in Mycobacterium tuberculosis.
    Gannoun-Zaki L; Alibaud L; Kremer L
    Antimicrob Agents Chemother; 2013 Jan; 57(1):629-32. PubMed ID: 23114755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the dehydratase component of the mycobacterial mycolic acid-synthesizing fatty acid synthase-II complex.
    Brown AK; Bhatt A; Singh A; Saparia E; Evans AF; Besra GS
    Microbiology (Reading); 2007 Dec; 153(Pt 12):4166-4173. PubMed ID: 18048930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the essential FAS II β-hydroxyacyl ACP dehydratase complex confer resistance to thiacetazone in Mycobacterium tuberculosis and Mycobacterium kansasii.
    Belardinelli JM; Morbidoni HR
    Mol Microbiol; 2012 Nov; 86(3):568-79. PubMed ID: 22994892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression, purification and crystallization of the (3R)-hydroxyacyl-ACP dehydratase HadAB complex from Mycobacterium tuberculosis.
    Dong Y; Li J; Qiu X; Yan C; Li X
    Protein Expr Purif; 2015 Oct; 114():115-20. PubMed ID: 26118698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of dehydratase component HadAB complex of mycobacterial FAS-II pathway.
    Biswas R; Dutta A; Dutta D; Hazra D; Banerjee DR; Basak A; Das AK
    Biochem Biophys Res Commun; 2015 Mar; 458(2):369-74. PubMed ID: 25656575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of KasA as the cellular target of an anti-tubercular scaffold.
    Abrahams KA; Chung CW; Ghidelli-Disse S; Rullas J; Rebollo-López MJ; Gurcha SS; Cox JA; Mendoza A; Jiménez-Navarro E; Martínez-Martínez MS; Neu M; Shillings A; Homes P; Argyrou A; Casanueva R; Loman NJ; Moynihan PJ; Lelièvre J; Selenski C; Axtman M; Kremer L; Bantscheff M; Angulo-Barturen I; Izquierdo MC; Cammack NC; Drewes G; Ballell L; Barros D; Besra GS; Bates RH
    Nat Commun; 2016 Sep; 7():12581. PubMed ID: 27581223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biosynthesis of mycolic acids in Mycobacterium tuberculosis relies on multiple specialized elongation complexes interconnected by specific protein-protein interactions.
    Veyron-Churlet R; Bigot S; Guerrini O; Verdoux S; Malaga W; Daffé M; Zerbib D
    J Mol Biol; 2005 Nov; 353(4):847-58. PubMed ID: 16213523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of NAS-21 and NAS-91 analogues as potential inhibitors of the mycobacterial FAS-II dehydratase enzyme Rv0636.
    Bhowruth V; Brown AK; Besra GS
    Microbiology (Reading); 2008 Jul; 154(Pt 7):1866-1875. PubMed ID: 18599816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,3-Diarylpyrazolyl-acylsulfonamides Target HadAB/BC Complex in
    Singh V; Grzegorzewicz AE; Fienberg S; Müller R; Khonde LP; Sanz O; Alfonso S; Urones B; Drewes G; Bantscheff M; Ghidelli-Disse S; Ioerger TR; Angala B; Liu J; Lee RE; Sacchettini JC; Krieger IV; Jackson M; Chibale K; Ghorpade SR
    ACS Infect Dis; 2022 Nov; 8(11):2315-2326. PubMed ID: 36325756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HadD, a novel fatty acid synthase type II protein, is essential for alpha- and epoxy-mycolic acid biosynthesis and mycobacterial fitness.
    Lefebvre C; Boulon R; Ducoux M; Gavalda S; Laval F; Jamet S; Eynard N; Lemassu A; Cam K; Bousquet MP; Bardou F; Burlet-Schiltz O; Daffé M; Quémard A
    Sci Rep; 2018 Apr; 8(1):6034. PubMed ID: 29662082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.